Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.



Question
Neostigmine is not an antagonist of rocuronium because it does not compete with rocuronium for the muscle end-plate receptor site. Neostigmine inhibits acetylcholinesterase, which allows acetylcholine to compete effectively with rocuronium and other nondepolarizing muscle relaxants for the [...], leading to a recovery of muscle tone. Therefore, its effect is at least a partial form of indirect antagonism.
Answer
receptor

Question
Neostigmine is not an antagonist of rocuronium because it does not compete with rocuronium for the muscle end-plate receptor site. Neostigmine inhibits acetylcholinesterase, which allows acetylcholine to compete effectively with rocuronium and other nondepolarizing muscle relaxants for the [...], leading to a recovery of muscle tone. Therefore, its effect is at least a partial form of indirect antagonism.
Answer
?

Question
Neostigmine is not an antagonist of rocuronium because it does not compete with rocuronium for the muscle end-plate receptor site. Neostigmine inhibits acetylcholinesterase, which allows acetylcholine to compete effectively with rocuronium and other nondepolarizing muscle relaxants for the [...], leading to a recovery of muscle tone. Therefore, its effect is at least a partial form of indirect antagonism.
Answer
receptor
If you want to change selection, open original toplevel document below and click on "Move attachment"

Parent (intermediate) annotation

Open it
ecause it does not compete with rocuronium for the muscle end-plate receptor site. Neostigmine inhibits acetylcholinesterase, which allows acetylcholine to compete effectively with rocuronium and other nondepolarizing muscle relaxants for the <span>receptor, leading to a recovery of muscle tone. Therefore, its effect is at least a partial form of indirect antagonism.<span><body><html>

Original toplevel document (pdf)

cannot see any pdfs

Summary

statusnot learnedmeasured difficulty37% [default]last interval [days]               
repetition number in this series0memorised on               scheduled repetition               
scheduled repetition interval               last repetition or drill

Details

No repetitions


Discussion

Do you want to join discussion? Click here to log in or create user.